Your Article Summary
See Latest ArticlesPolymorphisms in NF-kappaB Inhibitors and Risk of Epithelial Ovarian Cancer
BMC Cancer, 06/09/09
White KL et al. - Considering the number of single-SNP tests performed and null gene-level results, however, the authors conclude that NFKBIA and NFKBIB are not likely to harbor ovarian cancer risk alleles. Due to its biological significance in ovarian cancer, additional genes encoding NF-kB subunits, activating and inhibiting molecules, and signaling molecules warrant interrogation.
Related Articles
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 72%%
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival
British Journal of Cancer, 11/30/09
Relevance Score: 70%%
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09
Relevance Score: 70%%
Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09
Relevance Score: 70%%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 70%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells
Molecular Human Reproduction, 11/30/09
Nitrofurantoin transport by placental choriocarcinoma JAr cells: involvement of BCRP, OATP2B1 and other MDR transporters
Archives of Gynecology and Obstetrics, 11/25/09
Higher interleukin-18 and mannose-binding lectin are present in uterine lumen of patients with unexplained infertility
Reproductive BioMedicine Online, 11/25/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cervical cytology in patients with postmenopausal bleeding
Diagnostic Cytopathology, 11/30/09
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/30/09
Bevacizumab in the treatment of breast cancer
Cancer Treatment Reviews, 11/30/09